TIGER 2.0

Training in Checkpoint Inhibitors and Generation of a Network with the Establishment of Reference Centers for Immuno-Oncology in European Countries with Limited Financial Resources from Central and Southeastern Europe (CSEE) of CECOG.

Under the impression of the SARS-CoV-2 pandemic, CECOG proudly announces the expansion of its TIGER* Virtual Transborder Tumorboard Platform to a large number of Cancer Centers from the entirety of Europe.

Initially designed as a platform for the safeguarded virtual discussion and presentation of cancer patients, their diagnoses, and treatments and resulting side effects, the TIGER Platform has helped to guide oncologists from Central and South-eastern Europe (CEE) in clinical decision making based upon virtual discussions with leading cancer experts during the years 2018 and 2019. Under the impression of the current SARS-CoV-2 pandemic, we consider it timely to not only relaunch, but expand the TIGER platform to an expanded geographic area under the inclusion of oncologists from a large number of Cancer Centers.